FDA Inspection 1058736 — Xiangdong Zhou
The FDA completed an inspection of Xiangdong Zhou on Jun 28, 2018 in Chongqing. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 28, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chongqing (China)
Additional Details
Clinical Investigator (CI)